Introduction

Starting in January 2026, the Centers for Medicare & Medicaid Services (CMS) will pilot the WISeR Model—an AI-augmented prior authorization program under traditional Medicare. This initiative represents a groundbreaking shift from Medicare’s historically minimal PA requirements, with important implications for providers, patients, and policymakers. Let’s unpack what this means and how to get ready.

What Is the WISeR Model?

WISeR (Wasteful and Inappropriate Service Reduction) is a new six-year pilot (2026–2031) designed to reduce Medicare spending on clinically unsupported or low-value services—waste that accounts for up to 25% of U.S. healthcare costs. CMS will partner with technology firms using AI and automation, backed by clinician review, to streamline prior authorization for select services.

Where and What?

 

Geographic Scope: Pilot limited to six states—Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington

Targeted Services: Includes 17 outpatient services traditionally flagged for overuse or linked to waste, fraud, or abuse. Examples include:

Electrical nerve stimulators (e.g., deep brain stimulation, vagus nerve stimulation

Epidural steroid injections

Knee arthroscopy for osteoarthritis

Cervical fusion

Skin and tissue substitutes

Incontinence devices


How It Works

1. Pre-service option 

Providers can submit a voluntary prior authorization request using WISeR tools. If they don’t, their claim is automatically flagged for pre-payment review.

 

2. Tech-enabled review

 

AI systems perform initial evaluations. Denials or non-affirmations are escalated to licensed clinicians for final determination.
3. Incentivized oversight

 

Model participants—AI vendors—will earn a share of savings from denied claims (i.e., services deemed unnecessary).
4. Reporting & CICMS will monitor metrics like review accuracy, decision timeliness, and provider experience. Transparency in delays and denials is critical for oversight.

Why It Matters

  • Care Delays & Access Risks: Traditional Medicare is known for limited prior authorization, so patients and providers are concerned this pilot may strain workflows or delay access—especially for seniors with urgent needs.

  • Transparency & Accountability: Experts call for rigorous data reporting on delays, denials, and patient outcomes to safeguard care quality.

  • Possible Future Expansion: Should the pilot show positive results without compromising care, CMS may expand WISeR nationally, fundamentally reshaping prior authorization under Medicare.

Final Thoughts

The WISeR Model marks a significant milestone: the introduction of structured, tech-enhanced prior authorization into traditional Medicare. While aimed at reducing waste and improving efficiency, it raises understandable concerns about access, administrative burden, and unintended impacts on care quality.

By preparing early, aligning workflows, and closely monitoring developments, providers can navigate this transition proactively and help ensure that efficiency gains do not jeopardize patient care.